SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹87,693 Cr | ₹81,396 Cr | ₹77,225 Cr | ₹66,958 Cr | ₹64,110 Cr |
What is the latest Total Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹87,693 Cr |
| Mar2024 | ₹81,396 Cr |
| Mar2023 | ₹77,225 Cr |
| Mar2022 | ₹66,958 Cr |
| Mar2021 | ₹64,110 Cr |
How is Total Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹87,693 Cr | 7.74 | |
| Mar2024 | ₹81,396 Cr | 5.40 | |
| Mar2023 | ₹77,225 Cr | 15.33 | |
| Mar2022 | ₹66,958 Cr | 4.44 | |
| Mar2021 | ₹64,110 Cr | - | |
Compare Total Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,071.1 Cr | 2.8% | 6.3% | -1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,324.0 Cr | -2.1% | -2.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,235.0 Cr | -2.5% | 4.2% | 21.5% | Stock Analytics | |
| CIPLA | ₹123,294.0 Cr | 0% | -3.3% | 0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,336.0 Cr | 1.3% | -0.5% | -0.2% | Stock Analytics | |
| MANKIND PHARMA | ₹91,762.4 Cr | -1.5% | -10.3% | -12.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 2.8% |
6.3% |
-1.1% |
| SENSEX | 0.9% |
2.1% |
8.3% |
You may also like the below Video Courses